MAYPHARM Unveils HYALMASS AQUATOX, a Next-Generation Multi-Active Skin Solution for the Global Aesthetic Market
Why now
Thesis: Cosmetic launch news, no investable public entity named
Catalyst to watch: Distribution deals or parent company disclosure
Main risk: Promotional release, no financial figures given
Why it matters
A Korean cosmeceutical product launch is a company-level event without a named listed issuer.
Details
SEOUL, South Korea, Sept. 26, 2026 /PRNewswire/ -- MAYPHARM, a global aesthetic and cosmeceutical company, has announced the upcoming launch of HYALMASS AQUATOX, introducing a new multi-active formulation designed to respond to the rapidly evolving demands of the global aesthetic market....
Related assets & topics
HealthcareSources
- prnewswire · 2026-09-26 01:33 UTC
- prnewswire · 2026-09-26 00:55 UTC